硬膜外膿瘍治療の世界市場レポート 2025年

硬膜外膿瘍治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.6％で567億8,000万米ドルに成長します。予測期間の成長は、高齢者人口の増加、政府の取り組み、硬膜外膿瘍の研究開発への投資、脊髄硬膜外膿瘍の発生率の増加などに起因しています。予測期間における主な動向は、ヘルスケア技術の革新、硬膜外膿瘍治療におけるデジタルヘルス技術、硬膜外膿瘍診断・治療における人工知能（AI）、手頃な硬膜外膿瘍治療などです。

硬膜外膿瘍治療市場の成長は、神経疾患の有病率の上昇によって牽引されると予想されます。神経疾患には、脳、脊髄、神経を含む神経系に影響を及ぼす病状が含まれます。神経障害の一般的な例としては、急性脊髄損傷、アルツハイマー病、筋萎縮性側索硬化症（ALS）などがあります。硬膜外膿瘍治療は、これらの神経障害を管理するための重要なアプローチです。一般的には、膿瘍の適時な外科的ドレナージと抗生物質療法を行い、脊髄や神経の圧迫を防いで圧迫を緩和します。例えば、2022年3月現在、米国の非営利団体であるアルツハイマー病協会（Alzheimer's Association）は、2023年には65歳以上の米国人約670万人がアルツハイマー病患者であると報告しています。この数は2050年までに1270万人に増加すると予測されています。その結果、神経疾患の有病率の増加が硬膜外膿瘍治療市場拡大の原動力となっています。

静脈内薬物使用の有病率の増加が、今後の硬膜外膿瘍治療市場拡大の原動力になると予想されます。静脈内薬物使用では、皮下注射針と注射器を用いて薬物を血流に直接注入します。硬膜外膿瘍は、汚染された注射針や薬剤によって細菌や病原体が血流に混入することで発症する可能性があり、専門的な治療、ケア、予防プログラムに対する需要が高まっています。例えば、2024年7月、オーストラリアの政府機関であるオーストラリア保健福祉研究所（Australian Institute of Health and Welfare）は、2022年から2023年にかけて、14歳以上の個人の1.4％が生涯に少なくとも1回は薬物を注射したことがあり、0.2％が過去1年以内に薬物を注射したことがあると報告しました。その結果、静脈内薬物使用の増加が硬膜外膿瘍治療市場の成長を促進すると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界硬膜外膿瘍治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の硬膜外膿瘍治療市場：成長率分析
• 世界の硬膜外膿瘍治療市場の実績：規模と成長, 2019-2024
• 世界の硬膜外膿瘍治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界硬膜外膿瘍治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の硬膜外膿瘍治療市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 頭蓋内
• 脊髄内
• 世界の硬膜外膿瘍治療市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗真菌
• 抗生物質
• 手術
• 世界の硬膜外膿瘍治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 薬局
• 専門クリニック
• その他のエンドユーザー
• 世界の硬膜外膿瘍治療市場、頭蓋内サブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 脳膿瘍
• 硬膜下膿瘍
• 頭蓋内硬膜外膿瘍
• 世界の硬膜外膿瘍治療市場、脊髄内のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 頸部硬膜外膿瘍
• 胸部硬膜外膿瘍
• 腰部硬膜外膿瘍
• 仙骨硬膜外膿瘍

第7章 地域別・国別分析

• 世界の硬膜外膿瘍治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の硬膜外膿瘍治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 硬膜外膿瘍治療市場：競合情勢
• 硬膜外膿瘍治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Novartis AG
• Sanofi S.A.
• Bristol-Myers Squibb Company
• AstraZeneca plc
• Abbott Laboratories
• Eli Lilly and Company
• Gilead Sciences Inc.
• Amgen Inc.
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• Astellas Pharma
• Daiichi Sankyo Company Limited
• Boehringer Ingelheim International GmbH
• UCB Pharma
• Sun Pharmaceutical Industries Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 硬膜外膿瘍治療市場2029：新たな機会を提供する国
• 硬膜外膿瘍治療市場2029：新たな機会を提供するセグメント
• 硬膜外膿瘍治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Epidural abscess treatment refers to the treatment of a rare disorder that is characterized by an infection in the area between the bones of the skull or spine and the membranes covering the brain and spinal cord. Epidural abscess treatment is used to manage symptoms, slow down the progression of the disease and prevent complications.

The main types of epidural abscesses are intracranial and intraspinal. An intracranial epidural abscess refers to an infection between the skull's bones and the membranes encasing the brain and spinal cord. These can be treated by various treatments, including antifungals, antibiotics and surgery, which are used by various end-users, such as hospitals, pharmacies, specialty clinics and others.

The epidural abscess treatment market research report is one of a series of new reports from The Business Research Company that provides epidural abscess treatment market statistics, including epidural abscess treatment industry global market size, regional shares, competitors with an epidural abscess treatment market share, detailed epidural abscess treatment market segments, market trends and opportunities and any further data you may need to thrive in the epidural abscess treatment industry. This epidural abscess treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The epidural abscess treatment market size has grown strongly in recent years. It will grow from $41.11 billion in 2024 to $44.01 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to increasing prevalence of epidural abscesses, high healthcare expenditure, increasing awareness of the disease, growing demand for combination therapies.

The epidural abscess treatment market size is expected to see strong growth in the next few years. It will grow to $56.78 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to growing geriatric population, government initiatives, investment in epidural abscess research and development, growing incidence of spinal epidural abscesses. Major trends in the forecast period include innovations in healthcare technology, digital health technologies in epidural abscess care, artificial intelligence (AI) in epidural abscess diagnosis and treatment, affordable epidural abscess treatments.

The growth of the epidural abscess treatment market is expected to be driven by the rising prevalence of neurological disorders. Neurological disorders encompass medical conditions that affect the nervous system, which includes the brain, spinal cord, and nerves. Common examples of neurological disorders include acute spinal cord injury, Alzheimer's Disease, Amyotrophic Lateral Sclerosis (ALS), among others. Epidural abscess treatment is a crucial approach for managing these neurological disorders. It typically involves timely surgical drainage of the abscess and antibiotic therapy, which helps prevent compression of the spinal cord and nerves, relieving pressure. For instance, as of March 2022, the Alzheimer's Association, a nonprofit organization in the United States, reported that approximately 6.7 million Americans aged 65 and older are living with Alzheimer's in 2023. This number is projected to increase to 12.7 million by 2050. Consequently, the growing prevalence of neurological disorders is serving as a driving factor for the expansion of the epidural abscess treatment market.

The growing prevalence of intravenous drug use is expected to drive the expansion of the epidural abscess treatment market in the future. Intravenous drug use involves injecting drugs directly into the bloodstream with a hypodermic needle and syringe. This practice can lead to epidural abscesses when contaminated needles or drugs introduce bacteria or pathogens into the bloodstream, increasing the occurrence of the condition and fueling demand for specialized treatments, care, and prevention programs. For example, in July 2024, the Australian Institute of Health and Welfare, a government agency based in Australia, reported that in 2022-2023, 1.4% of individuals aged 14 and older had injected a drug at least once in their lifetime, while 0.2% had injected a drug within the past year. As a result, the rise in intravenous drug use is expected to drive the growth of the epidural abscess treatment market.

In March 2022, AbbVie Inc., a pharmaceutical company based in the United States, completed the acquisition of Syndesi Therapeutics SA for an approximate sum of $1 billion. This strategic acquisition is poised to facilitate AbbVie Inc.'s expansion within the field of neuroscience by incorporating novel synapse vesicle protein 2A modulators into its portfolio. Syndesi Therapeutics SA, headquartered in Belgium, is a biotechnology company with a focus on the development of therapies for spinal disorders, including conditions such as epidural abscesses.

Major companies operating in the epidural abscess treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Astellas Pharma, Daiichi Sankyo Company Limited, Boehringer Ingelheim International GmbH, UCB Pharma, Sun Pharmaceutical Industries Limited, Kyowa Hakko Kirin Co. Ltd., Ferring B.V., Hikma Pharmaceuticals PLC, Intas Pharmaceuticals Limited, Alembic Limited, Zydus Lifesciences Ltd., Lupin Limited, Mallinckrodt Pharmaceuticals.

North America was the largest region in the epidural abscess treatment market in 2024. The regions covered in epidural abscess treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the epidural abscess treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The epidural abscess treatment market consists of revenues earned by entities by providing surgical intervention, myelography, magnetic resonance imaging (MRI) and computed tomography (CT) scans. The market value includes the value of related goods sold by the service provider or included within the service offering. The epidural abscess treatment market also includes sales of vancomycin, gentamicin and ceftriaxone. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Epidural Abscess Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on epidural abscess treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for epidural abscess treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The epidural abscess treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Intracranial; Intraspinal
• 2) By Treatment: Antifungal; Antibiotics; Surgery
• 3) By End-User: Hospital; Pharmacy; Specialty Clinics; Other End-Users
• Subsegments:
• 1) By Intracranial: Brain Abscess; Subdural Abscess; Epidural Abscess in the Cranium
• 2) By Intraspinal: Cervical Epidural Abscess; Thoracic Epidural Abscess; Lumbar Epidural Abscess; Sacral Epidural Abscess
• Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; AbbVie Inc.; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Epidural Abscess Treatment Market Characteristics

3. Epidural Abscess Treatment Market Trends And Strategies

4. Epidural Abscess Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Epidural Abscess Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Epidural Abscess Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Epidural Abscess Treatment Market Growth Rate Analysis
• 5.4. Global Epidural Abscess Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Epidural Abscess Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Epidural Abscess Treatment Total Addressable Market (TAM)

6. Epidural Abscess Treatment Market Segmentation

• 6.1. Global Epidural Abscess Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intracranial
• Intraspinal
• 6.2. Global Epidural Abscess Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antifungal
• Antibiotics
• Surgery
• 6.3. Global Epidural Abscess Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Pharmacy
• Specialty Clinics
• Other End-Users
• 6.4. Global Epidural Abscess Treatment Market, Sub-Segmentation Of Intracranial, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Brain Abscess
• Subdural Abscess
• Epidural Abscess in the Cranium
• 6.5. Global Epidural Abscess Treatment Market, Sub-Segmentation Of Intraspinal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cervical Epidural Abscess
• Thoracic Epidural Abscess
• Lumbar Epidural Abscess
• Sacral Epidural Abscess

7. Epidural Abscess Treatment Market Regional And Country Analysis

• 7.1. Global Epidural Abscess Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Epidural Abscess Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Epidural Abscess Treatment Market

• 8.1. Asia-Pacific Epidural Abscess Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Epidural Abscess Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Epidural Abscess Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Epidural Abscess Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Epidural Abscess Treatment Market

• 9.1. China Epidural Abscess Treatment Market Overview
• 9.2. China Epidural Abscess Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Epidural Abscess Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Epidural Abscess Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Epidural Abscess Treatment Market

• 10.1. India Epidural Abscess Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Epidural Abscess Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Epidural Abscess Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Epidural Abscess Treatment Market

• 11.1. Japan Epidural Abscess Treatment Market Overview
• 11.2. Japan Epidural Abscess Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Epidural Abscess Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Epidural Abscess Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Epidural Abscess Treatment Market

• 12.1. Australia Epidural Abscess Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Epidural Abscess Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Epidural Abscess Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Epidural Abscess Treatment Market

• 13.1. Indonesia Epidural Abscess Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Epidural Abscess Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Epidural Abscess Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Epidural Abscess Treatment Market

• 14.1. South Korea Epidural Abscess Treatment Market Overview
• 14.2. South Korea Epidural Abscess Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Epidural Abscess Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Epidural Abscess Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Epidural Abscess Treatment Market

• 15.1. Western Europe Epidural Abscess Treatment Market Overview
• 15.2. Western Europe Epidural Abscess Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Epidural Abscess Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Epidural Abscess Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Epidural Abscess Treatment Market

• 16.1. UK Epidural Abscess Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Epidural Abscess Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Epidural Abscess Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Epidural Abscess Treatment Market

• 17.1. Germany Epidural Abscess Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Epidural Abscess Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Epidural Abscess Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Epidural Abscess Treatment Market

• 18.1. France Epidural Abscess Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Epidural Abscess Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Epidural Abscess Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Epidural Abscess Treatment Market

• 19.1. Italy Epidural Abscess Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Epidural Abscess Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Epidural Abscess Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Epidural Abscess Treatment Market

• 20.1. Spain Epidural Abscess Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Epidural Abscess Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Epidural Abscess Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Epidural Abscess Treatment Market

• 21.1. Eastern Europe Epidural Abscess Treatment Market Overview
• 21.2. Eastern Europe Epidural Abscess Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Epidural Abscess Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Epidural Abscess Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Epidural Abscess Treatment Market

• 22.1. Russia Epidural Abscess Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Epidural Abscess Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Epidural Abscess Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Epidural Abscess Treatment Market

• 23.1. North America Epidural Abscess Treatment Market Overview
• 23.2. North America Epidural Abscess Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Epidural Abscess Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Epidural Abscess Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Epidural Abscess Treatment Market

• 24.1. USA Epidural Abscess Treatment Market Overview
• 24.2. USA Epidural Abscess Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Epidural Abscess Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Epidural Abscess Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Epidural Abscess Treatment Market

• 25.1. Canada Epidural Abscess Treatment Market Overview
• 25.2. Canada Epidural Abscess Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Epidural Abscess Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Epidural Abscess Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Epidural Abscess Treatment Market

• 26.1. South America Epidural Abscess Treatment Market Overview
• 26.2. South America Epidural Abscess Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Epidural Abscess Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Epidural Abscess Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Epidural Abscess Treatment Market

• 27.1. Brazil Epidural Abscess Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Epidural Abscess Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Epidural Abscess Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Epidural Abscess Treatment Market

• 28.1. Middle East Epidural Abscess Treatment Market Overview
• 28.2. Middle East Epidural Abscess Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Epidural Abscess Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Epidural Abscess Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Epidural Abscess Treatment Market

• 29.1. Africa Epidural Abscess Treatment Market Overview
• 29.2. Africa Epidural Abscess Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Epidural Abscess Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Epidural Abscess Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Epidural Abscess Treatment Market Competitive Landscape And Company Profiles

• 30.1. Epidural Abscess Treatment Market Competitive Landscape
• 30.2. Epidural Abscess Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Epidural Abscess Treatment Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Sanofi S.A.
• 31.3. Bristol-Myers Squibb Company
• 31.4. AstraZeneca plc
• 31.5. Abbott Laboratories
• 31.6. Eli Lilly and Company
• 31.7. Gilead Sciences Inc.
• 31.8. Amgen Inc.
• 31.9. Teva Pharmaceutical Industries Ltd.
• 31.10. Mylan N.V.
• 31.11. Astellas Pharma
• 31.12. Daiichi Sankyo Company Limited
• 31.13. Boehringer Ingelheim International GmbH
• 31.14. UCB Pharma
• 31.15. Sun Pharmaceutical Industries Limited

32. Global Epidural Abscess Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Epidural Abscess Treatment Market

34. Recent Developments In The Epidural Abscess Treatment Market

35. Epidural Abscess Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Epidural Abscess Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Epidural Abscess Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Epidural Abscess Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer